Location: New York, NY
CIK: 0001017645 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 14, 2025
Total Value: $2.979B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALHC | ALIGNMENT HEALTHCARE | 60,993,323 | $1.136B | 38.1% | — | — | COM | 01625V104 |
| DLO | DLOCAL | 63,906,695 | $533M | 17.9% | — | — | CL A | G29018101 |
| XP | XP, INC | 29,617,733 | $407M | 13.7% | — | — | CL A | G98239109 |
| ALKT | ALKAMI | 9,645,318 | $253M | 8.5% | — | — | COM | 01644J108 |
| — | AKERO THERAPEUTICS | 5,233,989 | $212M | 7.1% | — | — | COM | 00973Y108 |
| CNTA | CENTESSA PHARMACEUTICALS | 9,681,818 | $139M | 4.7% | — | — | ADS | 152309100 |
| PHVS | PHARVARIS | 7,531,252 | $118M | 4.0% | — | — | COM | N69605108 |
| EWCZ | EUROPEAN WAX CENTER | 13,110,492 | $51.79M | 1.7% | — | — | CL A | 29882P106 |
| RPRX | ROYALTY PHARMA | 1,500,000 | $46.7M | 1.6% | — | — | CL A | G7709Q104 |
| IMCR | IMMUNOCORE | 1,261,684 | $37.43M | 1.3% | — | — | ADS | 45258D105 |
| RSKD | RISKIFIED | 5,324,998 | $24.6M | 0.8% | — | — | CL A | M8216R109 |
| — | ACELYRIN | 2,695,327 | $6.657M | 0.2% | — | — | COM | 00445A100 |
| ADAG | ADAGENE | 3,825,952 | $5.815M | 0.2% | — | — | ADS | 005329107 |
| — | WISH | 609,616 | $4.255M | 0.1% | — | — | CL A | 21077C305 |
| GROV | GROVE COLLABORATIVE | 2,474,859 | $3.341M | 0.1% | — | — | CL A | 39957D201 |